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ABSTRACT 
BACKGROUND 
           Insulin resistance and metabolic syndrome can be found even in individuals with normal 
weight defined by BMI. 
OBJECTIVE  
To study the  prevalence  of  Insulin resistance  using  HOMA index and metabolic syndrome in 
normal weight individuals and also to study the usefulness of Triglyceride glucose index in 
identifying insulin resistance among normal weight individuals. 
 METHODS AND MATERIALS 
                Clinical parameters, Insulin levels and other biochemical parameters were measured in 
220 subjects (normal weight individuals based on BMI) in both sex aged    21-50 years.JIS 
criteria was implemented for defining clinical and biochemical parameters. HOMA index and 
Triglyceride glucose index was assessed using Fasting blood sugar, Insulin level and triglyceride 
levels. The correlation of insulin resistance and metabolic syndrome and its prevalence were 
analyzed.  
RESULTS 
 The prevalence of Metabolic syndrome according to JIS definition was 25% in males (95%CI 
16.8%-35.5%) and 47% in females (95%CI 39.06%-55.3%).The prevalence of Insulin resistance 
(HOMA-IR) was 7.5% in males(95%CI 3.5%-15.4%)  and 8.6% in females(95%CI 5.0%-
14.3%). The Mean Weight, Height, Waist circumference,  Waist-Hip ratio , Skinfold thickness 
were significantly higher among men when compared with women whereas the skinfold 
thickness was significantly higher among women than men. HDL cholesterol was negatively 
correlated with HOMA index in both gender and was stastically significant.  There was no 
stastitically  significant correlation between  TyG index with clinical and biochemical 
parameters.  
CONCLUSION 
In conclusion our study provides evidence for prevalence of Insulin resistance and  Metabolic 
syndrome in normal weight individuals. There was no evidence for using trigyceride index to 
identify metabolically risky group among normal weight population.Considering these 
observations it has been proved that having a normal BMI doesn’t mean no risk for metabolic 
disorders and consequently for CVD.This situation reveals the need for change in routine 
screening of obese individuals defined by BMI alone and requires the incorporation of other 
clinical and biochemical parameters. 
There is a need for comprehensive studies addressing the complex interaction between  fat 
content, distribution and activity, and muscle mass , and their effect on metabolism, CVD risk 
and survival. 
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